期刊文献+

结核分枝杆菌Ag85B-MPT64融合基因的构建表达 被引量:5

Construction and expression of fusion gene encoding Mycobacterium tuberculosis Ag85B-MPT64 in eukaryotic cell
下载PDF
导出
摘要 目的 :构建结核分枝杆菌 (H37Rv)Ag85B MPT6 4融合基因并在真核细胞中表达 .方法 :采用序贯PCR(geneSOEing)法将Ag85B和MPT6 4编码基因用疏水甘氨酸接头(Gly4Ser) 3经PCR扩增融合 ,定向克隆入 pcDNA3.1(+)中 .采用脂质体转染法将pcDNA/Ag85B MPT6 4 (pcDNA/AM )转染COS 7细胞 ,用RT PCR、ELISA和斑点印迹法检测其表达 .结果 :Ag85B MPT6 4融合基因经双向DNA序列测定 ,碱基突变率为 0 .11%(2 /170 7) ,突变为无意义突变 ;重组质粒转染COS 7细胞后经检测证实 ,该融合基因能在真核细胞中表达 .结论 :成功地构建了Ag85B MPT6 4融合基因并在真核细胞中表达 。 AIM: To construct fusion gene encoding Mycobacterium tuberculosis Ag85B and MPT64 and to express fusion protein in COS 7 cell line. METHODS: Using gene SOEing method, fusion gene encoding H37Rv strain tubercle Ag85B MPT64 was linked with the(Gly4Ser)3 linker. The fusion gene was cloned into pcDNA3.1(+) and the recombinant plasmid pcDNA Ag85B MPT64 was transfected into COS 7 cells. The fusion protein expressed in COS 7 cells was determined by RT PCR, ELISA and dot blotting. RESULTS: Sequencing of Ag85B MPT64 fusion gene revealed that the mutation rate was 0.11%(2/1707) and the base mutation was nonsense. Expression of fusion gene in transfected COS 7 cells was justified.CONCLUSION: Fusion gene encoding Ag85B MPT64 was constructed successfully and the good antigenicity of fusion protein expressed in COS 7 cells was confirmed.
出处 《第四军医大学学报》 北大核心 2003年第12期1088-1090,共3页 Journal of the Fourth Military Medical University
基金 重庆市卫生局重点项目 (0 0 1 0 0 6)
关键词 分枝杆菌 结核 AG85B MPT64 重组融合蛋白质类 Mycobacterium tuberculosis Ag85B MPT64 recombinant fusion proteins
  • 相关文献

参考文献1

二级参考文献1

共引文献21

同被引文献51

  • 1呼西旦,蔡宏,李淑霞,田霞,朱玉贤.Ag85B核酸疫苗的免疫原性和保护性研究[J].中国人兽共患病杂志,2004,20(5):365-368. 被引量:7
  • 2温见翔,吴少庭,陈群,秦莉,袁仕善,林绮萍,雷明军,潘晖榕,张仁利,高世同,黄达娜.结核分枝杆菌ESAT-6蛋白在pET原核表达系统中的表达与纯化[J].中国热带医学,2004,4(6):897-899. 被引量:3
  • 3Tollefsen S,Vordermeier M,Ulsen I,et al.DNA injection in combination with electroporation a novel method for vaccination of farmed ruminants[J].Scandinavian J Immunol,2003,57(3):229-238.
  • 4Colditz G A,Brewer T F,Berkey C S,et al.Efficacy of BCG vaccine in the prevention of tuberculosis.Meta analysis of the published literature[J].J Am Med Asso,1994,271 (9):698-702.
  • 5Andersen P,Askgaard D,Gottschau A,et al.Identification of immunodominant antigens during infection with Mycobacterium tuberculosis[J].Scandinavian J Immunol,1992,36 (6):823-831.
  • 6Andersen P.Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins[J].Infect Immun,1994,62 (6):2 536-2 544.
  • 7Wilker H G,Harboe M.The antigen 85 complex:the major secreted product of M.tuberculosis[J].Microbiol Rev,1992,56(1):648-661.
  • 8萨姆布鲁克J 拉塞尔DW 黄培堂 译.分子克隆实验指南(上、下册)[M](第3版)[M].北京:科学出版社,2003,8..
  • 9Ulmer J B,Monyhomrty D L,Tsng A M,et al.DNA vaccines against tubeculosis[J].Gen Tuberculosis Navartis Found Symposium,1998,217:239-252.
  • 10Qrme I M,Mcmurray D N,Belisel J T.Tuberculosis vaccine development:Recent progress[J].Trends Microbiol,2001,9 (3):115-118.

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部